ReviewNAM journal2026
Defining benchmarking in the context of safety assessment of personal care and cosmetic products using New Approach Methodologies.
Review in NAM journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The concept of benchmark materials in the personal care and cosmetic industry is often based on the positioning of prototypes relative to the leading brand within a given product category. The main points of comparison are the market ranking, performance regarding consumers' perception, aesthetics, cost, complexity of the manufacturing process and patents covering the product and/or its components. Even though benchmark materials are often included when conducting safety tests of cosmetic and personal care products, the concept is rather loosely defined in toxicological profiling. The use of benchmarks becomes of particular interest when safety testing is based on New Approach Methodologies (NAMs) (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.